Group items tagged

In that mission, it has proved remarkably successful.

Tellingly, the scale of U.S. military aid — $47 billion over the first year of the conflict — is more than double that offered by European Union countries combined.

Coinciding with the global war on terrorism, the “big bang” expansion of 2004 — in which seven countries acceded — saw counterterrorism supersede democracy and human rights in alliance rhetoric. Stress on the need for liberalization and public sector reforms remained a constant.

In the realm of defense, the alliance was not as advertised. For decades, the United States has been the chief provider of weapons, logistics, air bases and battle plans

The organization pushed would-be partners to adhere to a liberal, pro-market creed, according to which — as President Bill Clinton’s national security adviser put it — “the pursuit of democratic institutions, the expansion of free markets” and “the promotion of collective security” marched in lock step. European military professionals and reform-minded elites formed a willing constituency, their campaigns boosted by NATO’s information apparatus.

By forbidding duplication of existing capabilities and prodding allies to accept niche roles, NATO has stymied the emergence of any semiautonomous European force capable of independent action. As for defense procurement, common standards for interoperability, coupled with the sheer size of the U.S. military-industrial sector and bureaucratic impediments in Brussels, favor American firms at the expense of their European competitors. The alliance, paradoxically, appears to have weakened allies’ ability to defend themselves.

Yet the paradox is only superficial. In fact, NATO is working exactly as it was designed by postwar U.S. planners, drawing Europe into a dependency on American power that reduces its room for maneuver. Far from a costly charity program, NATO secures American influence in Europe on the cheap

U.S. contributions to NATO and other security assistance programs in Europe account for a tiny fraction of the Pentagon’s annual budget — less than 6 percent by a recent estimate.

Surging demand has exacerbated this tendency as buyers rush to acquire tanks, combat aircraft and other weapons systems, locking into costly, multiyear contracts. Europe may be remilitarizing, but America is reaping the rewards.

In Ukraine, the pattern is clear. Washington will provide the military security, and its corporations will benefit from a bonanza of European armament orders, while Europeans will shoulder the cost of postwar reconstruction — something Germany is better poised to accomplish than the buildup of its military

The war also serves as a dress rehearsal for U.S. confrontation with China, in which European support cannot be so easily counted on. Limiting Beijing’s access to strategic technologies and promoting American industry are hardly European priorities, and severing European and Chinese trade is still difficult to imagine. Yet already there are signs that NATO is making headway in getting Europe to follow its lead in the theater

No matter their ascendance, Atlanticists fret over support for the organization being undermined by disinformation and cybermeddling.

Today, dissent is less audible than ever before.

Left parties in Europe, historically critical of militarism and American power, have overwhelmingly enlisted in the defense of the West: The trajectory of the German Greens, from fierce opponents of nuclear weapons to a party seemingly willing to risk atomic war, is a particularly vivid illustration

In an ideal epidemiological scenario, everyone would willingly deploy the full arsenal of COVID precautions, such as masking and forgoing crowded indoor activities, especially during waves. But that kind of all-out response no longer makes sense. “It’s probably not realistic to expect people to take precautions every time, perpetually, or even every winter or fall, unless there is a particularly concerning reason to do that,

when so few people feel that the potential benefit of dodging an infection is worth the inconvenience of precautions, what does it even mean to care about COVID?

people over 50 account for 93 percent of COVID-related deaths in the U.S., even though they represent just 35.7 percent of the population. As long as the death rate remains as high as it is, caring about COVID should mean orienting precautions to protect them.

Barring another Omicron-esque event, we thankfully won’t ever return to a moment where Americans obsess over COVID en masse. But this virus isn’t going away, so we can’t escape having a population that is split between the high-risk minority and the low-risk majority

Right now, Nuzzo told me, the language we use to describe one’s position on COVID is “black-and-white, absolutist—you either care or you don’t.” There is space between those extremes. At least for now, it’s the only way to compromise between the world we have and the world we want.

Of particular concern to Commerce are so-called frontier models. The phrase, popularized in the Washington lexicon by some of the very companies that seek to build these models—Microsoft, Google, OpenAI, Anthropic—describes a kind of “advanced” artificial intelligence with flexible and wide-ranging uses that could also develop unexpected and dangerous capabilities. By their determination, frontier models do not exist yet. But an influential white paper published in July and co-authored by a consortium of researchers, including representatives from most of those tech firms, suggests that these models could result from the further development of large language models—the technology underpinning ChatGPT

The threats of frontier models are nebulous, tied to speculation about how new skill sets could suddenly “emerge” in AI programs.

Among the proposals the authors offer, in their 51-page document, to get ahead of this problem: creating some kind of licensing process that requires companies to gain approval before they can release, or perhaps even develop, frontier AI. “We think that it is important to begin taking practical steps to regulate frontier AI today,” the authors write.

Microsoft, Google, OpenAI, and Anthropic subsequently launched the Frontier Model Forum, an industry group for producing research and recommendations on “safe and responsible” frontier-model development.

Shortly after the paper’s publication, the White House used some of the language and framing in its voluntary AI commitments, a set of guidelines for leading AI firms that are intended to ensure the safe deployment of the technology without sacrificing its supposed benefit

AI models advance rapidly, he reasoned, which necessitates forward thinking. “I don’t know what the next generation of models will be capable of, but I’m really worried about a situation where decisions about what models are put out there in the world are just up to these private companies,” he said.

For the four private companies at the center of discussions about frontier models, though, this kind of regulation could prove advantageous.

Convincing regulators to control frontier models could restrict the ability of Meta and any other firms to continue publishing and developing their best AI models through open-source communities on the internet; if the technology must be regulated, better for it to happen on terms that favor the bottom line.

The obsession with frontier models has now collided with mounting panic about China, fully intertwining ideas for the models’ regulation with national-security concerns. Over the past few months, members of Commerce have met with experts to hash out what controlling frontier models could look like and whether it would be feasible to keep them out of reach of Beijing

That the white paper took hold in this way speaks to a precarious dynamic playing out in Washington. The tech industry has been readily asserting its power, and the AI panic has made policy makers uniquely receptive to their messaging,

“Parts of the administration are grasping onto whatever they can because they want to do something,” Weinstein told me.

The department’s previous chip-export controls “really set the stage for focusing on AI at the cutting edge”; now export controls on frontier models could be seen as a natural continuation. Weinstein, however, called it “a weak strategy”; other AI and tech-policy experts I spoke with sounded their own warnings as well.

The decision would represent an escalation against China, further destabilizing a fractured relationship

Many Chinese AI researchers I’ve spoken with in the past year have expressed deep frustration and sadness over having their work—on things such as drug discovery and image generation—turned into collateral in the U.S.-China tech competition. Most told me that they see themselves as global citizens contributing to global technology advancement, not as assets of the state. Many still harbor dreams of working at American companies.

“If the export controls are broadly defined to include open-source, that would touch on a third-rail issue,” says Matt Sheehan, a Carnegie Endowment for International Peace fellow who studies global technology issues with a focus on China.

What’s frequently left out of considerations as well is how much this collaboration happens across borders in ways that strengthen, rather than detract from, American AI leadership. As the two countries that produce the most AI researchers and research in the world, the U.S. and China are each other’s No. 1 collaborator in the technology’s development.

Assuming they’re even enforceable, export controls on frontier models could thus “be a pretty direct hit” to the large community of Chinese developers who build on U.S. models and in turn contribute their own research and advancements to U.S. AI development,

Within a month of the Commerce Department announcing its blockade on powerful chips last year, the California-based chipmaker Nvidia announced a less powerful chip that fell right below the export controls’ technical specifications, and was able to continue selling to China. Bytedance, Baidu, Tencent, and Alibaba have each since placed orders for about 100,000 of Nvidia’s China chips to be delivered this year, and more for future delivery—deals that are worth roughly $5 billion, according to the Financial Times.

In some cases, fixating on AI models would serve as a distraction from addressing the root challenge: The bottleneck for producing novel biochemical weapons, for example, is not finding a recipe, says Weinstein, but rather obtaining the materials and equipment to actually synthesize the armaments. Restricting access to AI models would do little to solve that problem.

there could be another benefit to the four companies pushing for frontier-model regulation. Evoking the specter of future threats shifts the regulatory attention away from present-day harms of their existing models, such as privacy violations, copyright infringements, and job automation

“People overestimate how much this is in the interest of these companies,”

AI safety as a domain even a few years ago was much more heterogeneous,” West told me. Now? “We’re not talking about the effects on workers and the labor impacts of these systems. We’re not talking about the environmental concerns.” It’s no wonder: When resources, expertise, and power have concentrated so heavily in a few companies, and policy makers are seeped in their own cocktail of fears, the landscape of policy ideas collapses under pressure, eroding the base of a healthy democracy.

The United States, Europe and China are, in different ways, all speeding up the transition to a green economy.

The first to go is the era of easy money. This isn’t a short-term response to President Biden’s much-needed post-pandemic fiscal stimulus. (In fact, that stimulus is exactly what kept the U.S. economy resilient while peers flagged, according to a recent New York Fed report.

This is a return to an economy that is more rational and hardheaded. Not all companies, or stocks, are created equal. Many have too much debt on their books.

Years of easy money propped up everything. A higher cost of capital will be painful temporarily, but it will give markets what they’ve needed for years — a reason for investors to sort out risky investments

Cheap energy is over, too. One outcome of Russia’s invasion of Ukraine is the realization (especially in Europe) that getting crucial commodities from autocrats is never a good idea

At home, that means more wind and solar farms, more electric cars and more diverse supply chains to build it all. This will be inflationary in the short term, as it means manufacturing new products and investing in new technologies

The bond market won’t like it, and there will be calls to return to the old ways, particularly if inflation continues to bite.

But it will be strongly deflationary if we can make the shift.

Finally, the era of cheap labor has ended

Wages are rising, and we’ve seen more labor activity, including strikes, this year than in the past four decades. More will follow. This is an appropriate response to decades of wage stagnation amid record corporate profits

Unions, but also non-union workers in many areas of the economy including construction and manufacturing, have been buoyed by the largest infrastructure investment since the 1950s — which has given them negotiating power that they haven’t had in years

Meanwhile, companies in the service sector are reconsidering their usual hire-and-fire-fast approach, having been trained by the pandemic to hang onto employees as long as possible.

Yes, artificial intelligence could throw a spammer in all this. CEOs are looking to use it to bring down labor costs. But workers today are becoming more proactive about demanding more control of both trade and technology;

The end of cheap is a huge shift. It means Main Street rather than Wall Street will drive the economy. It will make for a more balanced and resilient economy.

All of that is going away or gone. A decade and a half of go-go speculation is finished. The era of cheap is kaput.

cheap isn’t really cheap. It’s just putting your troubles on layaway.

‘Odds are, people are going to get sick this year,’”

In typical years, flu hospitalizes an estimated 140,000 to 710,000 people in the United States alone; some years, RSV can add on some 200,000 more. “Our baseline has never been great,” Yvonne Maldonado, a pediatrician at Stanford, told me. “Tens of thousands of people die every year.”

this time of year, on top of RSV, flu, and COVID, we also have to contend with a maelstrom of other airway viruses—among them, rhinoviruses, parainfluenza viruses, human metapneumovirus, and common-cold coronaviruses.

Illnesses not severe enough to land someone in the hospital could still leave them stuck at home for days or weeks on end, recovering or caring for sick kids—or shuffling back to work

“This is a more serious pathogen that is also more infectious,” Ajay Sethi, an epidemiologist at the University of Wisconsin at Madison, told me. In the past year, COVID-19 has killed some 80,000 Americans—a lighter toll than in the three years prior, but one that still dwarfs that of the worst flu seasons in the past decade.

Globally, the only infectious killer that rivals it in annual-death count is tuberculosis

Rivers also pointed to CDC data that track trends in deaths caused by pneumonia, flu, and COVID-19. Even when SARS-CoV-2 has been at its most muted, Rivers said, more people have been dying—especially during the cooler months—than they were at the pre-pandemic baseline.

This year, for the first time, millions of Americans have access to three lifesaving respiratory-virus vaccines, against flu, COVID, and RSV. Uptake for all three remains sleepy and halting; even the flu shot, the most established, is not performing above its pre-pandemic baseline.

COVID could now surge in the summer, shading into RSV’s autumn rise, before adding to flu’s winter burden, potentially dragging the misery out into spring. “Based on what I know right now, I am considering the season to be longer,” Rivers said.

barring further gargantuan leaps in viral evolution, the disease will continue to slowly mellow out in severity as our collective defenses build; the virus may also pose less of a transmission risk as the period during which people are infectious contracts

even if the dangers of COVID-19 are lilting toward an asymptote, experts still can’t say for sure where that asymptote might be relative to other diseases such as the flu—or how long it might take for the population to get there.

it seems extraordinarily unlikely to ever disappear. For the foreseeable future, “pretty much all years going forward are going to be worse than what we’ve been used to before,”

although a core contingent of Americans might still be more cautious than they were before the pandemic’s start—masking in public, testing before gathering, minding indoor air quality, avoiding others whenever they’re feeling sick—much of the country has readily returned to the pre-COVID mindset.

When I asked Hanage what precautions worthy of a respiratory disease with a death count roughly twice that of flu’s would look like, he rattled off a familiar list: better access to and uptake of vaccines and antivirals, with the vulnerable prioritized; improved surveillance systems to offer  people at high risk a better sense of local-transmission trends; improved access to tests and paid sick leave

Without those changes, excess disease and death will continue, and “we’re saying we’re going to absorb that into our daily lives,” he said.

And that is what is happening.

last year, a CDC survey found that more than 3 percent of American adults were suffering from long COVID—millions of people in the United States alone.

“We get used to things we could probably fix.” The years since COVID arrived set a horrific precedent of death and disease; after that, this season of n+1 sickness might feel like a reprieve. But compare it with a pre-COVID world, and it looks objectively worse. We’re heading toward a new baseline, but it will still have quite a bit in common with the old one: We’re likely to accept it, and all of its horrors, as a matter of course.

it is palpable: what happens in the UK and Europe doesn’t stay in the UK and Europe.

In the past couple of weeks, the UK and several countries in Europe, including Germany, France and Switzerland, are experiencing a new wave.

This is the sixth warning from the UK and Europe to the United States.

Wastewater surveillance is relatively sparse in the United States, but 15% of the 410 sites where it was conducted between 24 February to 10 March 2022 showed a greater than 1000% increase compared with the prior 15-day period

the BA.2 variant is gaining steam in the United States and is now accounting for more than 30% of new cases.

Rather than focusing on what precisely is driving the new wave, the imperative is to drive some preventive action.

As with the first five warnings from the UK and Europe, the United States did not take heed. Instead of proactively gearing up with non-pharmaceutical interventions (masks, quality of masks, distancing, air filtration, ventilation, aggressive testing, etc.), it just reacted to the surges when they were manifest.

Now we are at a point with very low vaccination and booster rates, only 64% of the populations has had two shots, and 29% three shots. That puts the United States at 65th and 70th in the world ranking of countries, respectively.

Not only is there a gaping hole in our immunity wall, but the $58bn budget of the American Pandemic Prepared Plan (AP3) advanced by the White House to comprehensively address the deficiencies was gutted by the Senate, reduced to $2bn, now threatening to cancel the order of more than 9.2m Paxlovid pills, the Test-to Treat program announced at the State of the Union address, along with better data, wastewater surveillance, efforts to develop a pan-coronavirus vaccine, research on long Covid, and many other critical public health measures.

We haven’t even seen a new, major variant yet, but there are too many reasons to believe that is likely in the months ahead, owing to extensive animal reservoirs and documented cases of spillover to humans, a large number of immunocompromised people in whom the virus can undergo accelerated evolution, rare but increasingly seen co-infections, and lack of containment of the virus globally.

Unfortunately, we have a mindset that the pandemic is over, which couldn’t be further than the truth

dd to all this is what is happening in China, which has fully relied on a zero-Covid policy, resulting in very little natural immunity, and vaccines that have weak efficacy against Omicron

that would be on par with what we experience with flu viruses, which scientists estimate hit us about every two to five years, less often in adulthood. It also matches up well with the documented cadence of the four other coronaviruses that seasonally trouble humans, and cause common colds.

For now, every infection, and every subsequent reinfection, remains a toss of the dice. “Really, it’s a gamble,” says Ziyad Al-Aly, a clinical epidemiologist and long-COVID researcher at Washington University in St. Louis. Vaccination and infection-induced immunity may load the dice against landing on severe disease, but that danger will never go away completely, and scientists don’t yet know what happens to people who contract “mild” COVID over and over again

Or maybe not. This virus seems capable of tangling into just about every tissue in the body, affecting organs such as the heart, brain, liver, kidneys, and gut; it has already claimed the lives of millions, while saddling countless others with symptoms that can linger for months or years.

considering our current baseline, “less dangerous” could still be terrible—and it’s not clear exactly where we’re headed. When it comes to reinfection, we “just don’t know enough,”

Perhaps, as several experts have posited since the pandemic’s early days, SARS-CoV-2 will just become the fifth cold-causing coronavirus.

A third or fourth bout might be more muted still; the burden of individual diseases may be headed toward an asymptote of mildness that holds for many years

Future versions of SARS-CoV-2 could continue to shape-shift out of existing antibodies’ reach, as coronaviruses often do. But the body is flush with other fighters that are much tougher to bamboozle—among them, B cells and T cells that can quash a growing infection before it spirals out of control

Those protections tend to build iteratively, as people see pathogens or vaccines more often. People vaccinated three times over, for instance, seem especially well equipped to duke it out with all sorts of SARS-CoV-2 variants, including Omicron and its offshoots.

promising patterns: Second infections and post-vaccination infections “are significantly less severe,” she told me, sometimes to the point where people don’t notice them at all

Bodies, wised up to the virus’s quirks, can now react more quickly, clobbering it with sharper and speedier strikes.

“There are still very good reasons” to keep exposures few and far between, Landon, of the University of Chicago, told me. Putting off reinfection creates fewer opportunities for harm: The dice are less likely to land on severe disease (or chronic illness) when they’re rolled less often overall. It also buys us time to enhance our understanding of the virus, and improve our tools to fight it.

Immunity, though, is neither binary nor permanent. Even if SARS-CoV-2’s assaults are blunted over time, there are no guarantees about the degree to which that happens, or how long it lasts.

A slew of factors could end up weighting the dice toward severe disease—among them, a person’s genetics, age, underlying medical conditions, health-care access, and frequency or magnitude of exposure to the virus.

for everyone else, no amount of viral dampening can totally eliminate the chance, however small it may be, of getting very sick.

Long COVID, too, might remain a possibility with every discrete bout of illness. Or maybe the effects of a slow-but-steady trickle of minor, fast-resolving infections would sum together, and bring about the condition.

Every time the body’s defenses are engaged, it “takes a lot of energy, and causes tissue damage,” Thomas told me. Should that become a near-constant barrage, “that’s probably not great for you.”

Bodies are resilient, especially when they’re offered time to rest, and she doubts that reinfection with a typically ephemeral virus such as SARS-CoV-2 would cause mounting damage. “The cumulative effect is more likely to be protective than detrimental,” she said, because of the immunity that’s laid down each time.

people who have caught the virus twice or thrice may be more likely to become long-haulers than those who have had it just once.

Some other microbes, when they reinvade us, can fire up the immune system in unhelpful ways, driving bad bouts of inflammation that burn through the body, or duping certain defensive molecules into aiding, rather than blocking, the virus’s siege. Researchers don’t think SARS-CoV-2 will do the same. But this pathogen is “much more formidable than even someone working on coronaviruses would have expected,

Seasonal encounters with pathogens other than SARS-CoV-2 don’t often worry us—but perhaps that’s because we’re still working to understand their toll. “Have we been underestimating long-term consequences from other repeat infections?” Thomas said. “The answer is probably, almost certainly, yes.”

the rhythm of reinfection isn’t just about the durability of immunity or the pace of viral evolution. It’s also about our actions and policies, and whether they allow the pathogen to transmit and evolve. Strategies to avoid infection—to make it as infrequent as possible, for as many people as possible—remain options, in the form of vaccination, masking, ventilation, paid sick leave, and more.

Gordon and Swartz are both hopeful that the slow accumulation of immunity will also slash people’s chances of developing long COVID.

The outlooks of the experts I spoke with spanned the range from optimism to pessimism, though all agreed that uncertainty loomed. Until we know more, none were keen to gamble with the virus—or with their own health. Any reinfection will likely still pose a threat, “even if it’s not the worst-case scenario,” Abdool Karim told me. “I wouldn’t want to put myself in that position.”

Apple and Google said they allow users to create audiobooks free of charge that use digitally replicated human voices. The voices featured in audiobooks generated by Apple and Google come from real people, whose voices helped train their automated-narration engines.

Ms. Papel said there is still plenty of work for professional narrators because the new era of AI auto-narration is just getting under way, though she said that might not be the case in the future.

“From what I can see, human narrators are freaking out,

Melissa Papel, a Paris-born actress who records from her home studio in Los Angeles, said she recorded eight hours of content for DeepZen, reading in French from different books. “One called for me to read in an angry way, another in a disgusted way, a humorous way, a dramatic way,” she said.

Charles Watkinson, director of the University of Michigan Press, said the publisher has made about 100 audiobooks using Google’s free auto-narrated audiobook platform since early last year. The new technology made those titles possible because it eliminated the costs associated with using a production studio, support staff and human narrators.

“I understood that they would use my voice to teach software how to speak more humanly,” Ms. Papel said. “I didn’t realize they could use my voice to pronounce words I didn’t say. That’s incredible.”

DeepZen pays its narrators a flat fee plus a royalty based on the revenue the company generates from different projects. The agreements span multiple years

a national union that represents performers, including professional audiobook narrators, said he expects AI to eventually disrupt the industry.

Audiobook sales rose 7% last year, according to the Association of American Publishers, while print book sales declined by 5.8%, according to book tracker Circana BookScan.

eepZen says it has signed deals with 35 publishers in the U.S. and abroad and is working with 25 authors.

Josiah Ziegler, a psychiatrist in Fort Collins, Colo., last year created Intellectual Classics, which focuses on nonfiction works that are out of copyright and don’t have an audiobook edition. 

He chose Mr. Herrmann as the narrator for “The War with Mexico,” a work by Justin H. Smith that won the 1920 Pulitzer Prize for history whose audiobook version Dr. Ziegler expects to publish later this year.

DeepZen, which has created nearly a hundred audiobooks featuring Mr. Herrmann’s voice, is pursuing the rights of other well-known stars who have died.

how many are aware that President Biden is among the more popular — well, less unpopular — leaders in the Western world?

First, let’s talk about some other international comparisons that seem relevant to the current situation.

But public perception of our economic performance is strongly colored by rising prices. Inflation — the rate at which prices are rising — has subsided a lot, but prices haven’t and won’t come down

No matter what we did, many people were going to die — but the death toll was affected by politics, perhaps especially by the way vaccines became a front in the culture war. And America had a really bad pandemic, even compared with its peers. U.S. life expectancy was already lagging behind comparable countries’ by 2019, but the gap widened after Covid-19 struck.

On the other hand, the U.S. economy experienced an exceptionally strong bounce back from the pandemic recession. Even after adjusting for inflation, U.S. gross domestic product per capita is up 7 percent since the eve of the pandemic, greatly exceeding growth in other major wealthy economies

This would seem on the face of it to say something good about Biden’s economic policies.

Although we hear politicians on the campaign trail trying to make hay with the old Reagan-era question — Are you better off than you were four years ago? — there’s a lot of amnesia about what was actually happening in 2020, namely a deadly, terrifying pandemic

there have been huge recriminations against policymakers, both the Biden administration and the Federal Reserve, either for supposedly causing the bout of inflation or at any rate failing to prevent it.

the similarities between the wealthiest nations are more revealing than their differences.

Inflation surged almost everywhere after the pandemic. And if you take care to compare “apples to Äpfel” — to use the same consumer price measures — inflation has been remarkably similar in different countries.

Since the eve of the pandemic, the Harmonized Index of Consumer Prices has risen 19.6 percent in the United States and 19.8 percent in the euro area.

This strongly suggests that pandemic-related disruptions, rather than national policies, were inflation’s main driver.

Still, inflation rankles voters. Even when income growth exceeds inflation, as it has in the United States, people tend to feel that they earned their higher wages only to have them snatched away by higher prices

this is probably the most important reason that, according to tracking polls conducted by Morning Consult, every single leader of a Group of 7 nation is underwater, with more voters disapproving than approving of their leadership.

So who’s the winner of this unpopularity contest? Who has the least bad net approval? The answer is Joe Biden, with Giorgia Meloni of Italy a close second. The other Group of 7 leaders are even more unpopular

this has political consequences

every political analysis that says the fault for Biden’s low approval lies with the president and his campaign — that he’s too old (although that narrative, after suddenly peaking, mostly faded away after his State of the Union address) or is out of touch with the concerns of “real” Americans — needs to explain why he’s doing less badly than his foreign peers.